These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2933540)

  • 21. Body fluid volume status and the renal response to atrial natriuretic peptide in rats.
    Honrath U; Chong CK; Sonnenberg H
    Can J Physiol Pharmacol; 1998 Dec; 76(12):1156-60. PubMed ID: 10326839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of a synthetic atrial natriuretic polypeptide on intrarenal hemodynamics in dogs.
    Abe Y; Tamaki T; Fukui K; Fujisawa Y; Yamamoto A; Iwao H
    Eur J Pharmacol; 1987 Sep; 141(2):219-24. PubMed ID: 2960551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Central cardiovascular and renal effects of atrial natriuretic peptide].
    Zhao G; Luo H; Ho SY
    Sheng Li Xue Bao; 1991 Dec; 43(6):537-47. PubMed ID: 1839084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The haemodynamic, renal and endocrine effects of alpha-human atrial natriuretic polypeptide in normotensive people and patients with essential hypertension.
    Ishii M; Sugimoto T; Matsuoka H; Hirata Y; Ishimistu T; Fukui K; Sugimoto T; Kangawa K; Matsuo H
    J Hypertens Suppl; 1986 Dec; 4(6):S542-5. PubMed ID: 2956389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natriuretic and hypotensive effects of chronically administered alpha-human atrial natriuretic polypeptide in sodium-deplete or replete conscious spontaneously hypertensive rats.
    Kida O; Kondo K; Tanaka K
    J Hypertens Suppl; 1986 Dec; 4(6):S529-31. PubMed ID: 2956387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic, renal, and hormonal responses to alpha-human atrial natriuretic peptide in patients with congestive heart failure.
    Saito H; Ogihara T; Nakamaru M; Hara H; Higaki J; Rakugi H; Tateyama H; Minamino T; Iinuma K; Kumahara Y
    Clin Pharmacol Ther; 1987 Aug; 42(2):142-7. PubMed ID: 2955995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiosuppressive effect of alpha-human atrial natriuretic polypeptide (alpha-hANP) in spontaneously hypertensive rats.
    Sasaki A; Kida O; Kangawa K; Matsuo H; Tanaka K
    Eur J Pharmacol; 1985 Sep; 115(2-3):321-4. PubMed ID: 2933268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-response analysis of acute hypotensive and renal effects of atrial natriuretic peptide in the rat.
    Caron N; Dupuis V; Michel A; Kramp R
    Arch Int Pharmacodyn Ther; 1995; 329(3):379-96. PubMed ID: 8546537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The renal, cardiovascular and hormonal actions of human atrial natriuretic peptide in man; effects of indomethacin.
    Miyamori I; Ikeda M; Matsubara T; Okamoto S; Koshida H; Yasuhara S; Morise T; Takeda R
    Br J Clin Pharmacol; 1987 Apr; 23(4):425-31. PubMed ID: 2953384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intravenously administered beta-human atrial natriuretic polypeptide in humans.
    Itoh H; Nakao K; Mukoyama M; Shiono S; Morii N; Sugawara A; Yamada T; Saito Y; Arai H; Hosoda K
    Hypertension; 1988 Jun; 11(6 Pt 2):697-702. PubMed ID: 2968953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of alpha-human natriuretic peptide on renal hemodynamics and diuresis in dogs and perfused rat kidneys.
    Watanabe I; Goto F
    Jpn Circ J; 1994 Feb; 58(2):136-42. PubMed ID: 8196155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous alpha-human atrial natriuretic polypeptide in normal volunteers: effects on renal, cardiovascular and endocrine functions.
    Tang J; Xie CW; Lin XW; Yang Q; Liu DQ; Huang DY; Shi SG; Qu HT; Wang YL; Zhang TS
    Chin Med J (Engl); 1985 Nov; 98(11):783-6. PubMed ID: 2938893
    [No Abstract]   [Full Text] [Related]  

  • 33. Renal hemodynamic and natriuretic effects of atrial natriuretic factor.
    Maack T; Atlas SA; Camargo MJ; Cogan MG
    Fed Proc; 1986 Jun; 45(7):2128-32. PubMed ID: 3011521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natriuresis during atrial distension and a concurrent decline in plasma atriopeptin.
    Goetz KL; Wang BC; Bie P; Leadley RJ; Geer PG
    Am J Physiol; 1988 Aug; 255(2 Pt 2):R259-67. PubMed ID: 2970235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-human atrial natriuretic polypeptide inhibits steroidogenesis in cultured human adrenal cells.
    Higuchi K; Nawata H; Kato K; Ibayashi H; Matsuo H
    J Clin Endocrinol Metab; 1986 May; 62(5):941-4. PubMed ID: 3007561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial natriuretic factor (auriculin): structure and biological effects.
    Atlas SA; Kleinert HD; Camargo MJ; Volpe M; Laragh JH; Lewicki JA; Maack T
    J Clin Hypertens; 1985 Jun; 1(2):187-98. PubMed ID: 2941526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal effects of a synthetic alpha-human atrial natriuretic polypeptide (alpha-hANP) in anesthetized dogs.
    Yukimura T; Ito K; Takenaga T; Yamamoto K; Kangawa K; Matsuo H
    Eur J Pharmacol; 1984 Aug; 103(3-4):363-6. PubMed ID: 6237925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis.
    Laragh JH
    N Engl J Med; 1985 Nov; 313(21):1330-40. PubMed ID: 2932646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of inhibitory effect of alpha-human atrial natriuretic polypeptide on aldosteronogenesis in aldosterone-producing adenoma.
    Higuchi K; Nawata H; Kato K; Ibayashi H; Matsuo H
    J Clin Endocrinol Metab; 1986 Jul; 63(1):192-6. PubMed ID: 3011838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Permissive action of glucocorticoid substitution therapy on the effects of atrial natriuretic peptide (hANP) in patients with adrenocortical insufficiency.
    Damjancic P; Vierhapper H
    Exp Clin Endocrinol; 1990 Aug; 95(3):315-21. PubMed ID: 2174002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.